Vaccine For Glioblastoma Multiforme Brain Cancer Shows Promise In New Study
The patients in the Agenus study were treated once weekly for four weeks, followed by biweekly injections until the vaccine
vaccine glioblastoma multiforme brain cancer show promise new study patient agenus study treat weekly week follow biweekly injection vaccine